跳至主要内容
临床试验/NCT01534936
NCT01534936已完成不适用

Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary.

AstraZeneca1 个研究点 分布在 1 个国家目标入组 2,153 人开始时间: 2012年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
2,153
试验地点
1
主要终点
Change from baseline on clinical global impression scale up to 6 months of schizophrenic outpatients with affective symptoms.

研究概览

简要总结

This is a noninterventional observational study lead amongst psychiatrists, to assess the the overall status of schizophrenic outpatients with affective symptoms treated with atypical antipsychotics.

详细描述

Atypical antipsychotics in the treatment of affective symptoms of schizophrenia in Hungary

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Schizophrenic outpatients diagnosis based on DSM -IV above 18 years of age with affective symptoms.
  • Atypical antipsychotic treatment at least for a month before study inclusion.

排除标准

  • Pregnancy.
  • Hepatic disease.
  • Diabetes mellitus.
  • Severe cerebro- or cardiovascular disease.

结局指标

主要结局

Change from baseline on clinical global impression scale up to 6 months of schizophrenic outpatients with affective symptoms.

时间窗: 3 and 6 months

The Clinical Global Impression Scale (CGI) is a brief clinician-rated instrument. The CGI severity of illness measure (CGI-S) is rated from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). The CGI global improvement measure (CGI-I) is rated from 1 (very much improved) to 7 (very much worse). "0" stands for "not assessed". Means and standard deviations (SD) for CGI-S(baseline), CGI-S (1.visit) CGI-S (2.visit) and for CGI-I will be calculated.

次要结局

  • Description of the relation between and the change of affective symptoms and overall clinical status.(3 and 6 months)
  • Assessment of the efficacy of different atypical antipsychotics in the treatment of schizophrenia with affective symptoms measured by the difference in Raskin Scale.(From baseline up to 6 months)
  • Assessment of the efficacy of different atypical antipsychotics in the treatment of schizophrenia with affective symptoms measured by the difference in CGI-S (CGI severity of illness measure) and CGI-I (CGI global improvement measure).(From baseline up to 6 months)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验